Welcome

to-BBB is developing medicines for the treatment of devastating brain diseases. Our proprietary liposomal G-Technology® facilitates entry to the brain while simultaneously enabling sustained delivery of systemically administered therapeutics. Our technology has been shown to be compatible with approved as well as novel therapeutic entities. We have two clinical programs, one targeting multiple indications of brain cancers and the other neuroinflammatory diseases.

 


Meet us at

MS Boston (ECTRIMS) 2014

» 10 September 2014

ESMO - Madrid

» 26 September 2014

Biotech in Europe Forum - Basel

» 30 September 2014

EANO -Turin

» 09 October 2014

BIO Europe - Frankfurt

» 03 November 2014

SNO conference - Miami

» 13 November 2014

SABC symposium - San Antonio

» 09 December 2014

Pipeline

Read more